Current Edition

Editorial Archive

Blister machine technology in use for better compliance

Oliver Naucke of Uhlmann Pac-Systeme GmbH explains the concept of – “7×4 Box – My week´s medicine”. To ensure consistent compliance, especially in the case of chronically ill and older people, 7×4 Pharma GmbH commenced a pilot project with the compulsory health insurance AOK Berlin in 2009 to supply patients with individually-packed blisters with their weekly medication.

Continue Reading →
Editorial Archive

Innovation in malaria drug packaging: Coartem® and Coartem® Dispersible

There are approximately 881,000 malaria-related deaths every year. Drs Nadia elMasry and Chemtai Kipkeu show how Novartis Pharma AG is doing in the fight against malaria.

Continue Reading →
Editorial Archive

Braille labelling on medicines – the clock is ticking!

Anne Dallison of Design Cognition Ltd argues that this change will dramatically increase the safety and sense of security of the many Braille users in Europe.

Continue Reading →
Editorial Archive

Combating Drug Counterfeiting Using Advanced Packaging Technologies

This article by Richard Burhouse of Payne Security discusses the issue of counterfeit drugs, outlines current legislation and discusses the latest secure packaging technologies and their unique benefits.

Continue Reading →
Editorial Archive

Global standard for medication adherence monitoring

Chris Johnson of CYPAK writes on how products conforming to IEEE 11073-10472 and Continua Health Alliance will have a major impact on the way pharmaceuticals are packaged and delivered in future.

Continue Reading →
Editorial Archive

Considerations for Choosing a CMO

This article by Hyaluron Contract Manufacturing focuses on elements to consider when choosing to outsource drug production.

Continue Reading →
Editorial Archive

Emulsions – established and promising drug carriers for parenteral administration

Anton Gerdenitsch of Fresenius Kabi evaluates the proposition that, when emulsions are carefully designed with respect to the target and route of administration, they may provide one solution to some of the delivery problems posed by new classes of active molecules, such as peptides, proteins, genes, and oligonucleotides. They may also extend the therapeutic potential of established drugs.

Continue Reading →
Editorial Archive

The Next Generation of Clinical Supply Shipment Monitoring

Nathan Kohner of Almac Group explains that a process for the efficient visibility of the success of temperature control increases detectability, and therefore reduces the risk factor.

Continue Reading →
Clinical Research v2i1

Phase I: As Relevant as Ever?

Brian Sanderson of Chiltern (Early Phase) argues that although new studies have their place, the more traditional Phase I studies have evolved over the years, with new thinking being applied along with a wealth of expertise available to add value.

Continue Reading →
Clinical Research v2i1

Centralizing ECGs for efficient, accurate cardiac safety assessments in clinical trials

Amy Furlong, Executive Vice President, Cardiac Safety Operations at ERT shows how centralising the process of collection and standardisation of quality ECG data, and employing digital ECG systems and a core laboratory, not only reduces inconsistencies that may occur from site to site, but in addition helps to alleviate laboratory and site workloads.

Continue Reading →